Management of Abdominal Pain in Pediatric Patients

Immediate Pain Assessment and Relief

• The American Academy of Pediatrics recommends administering pain medication immediately upon presentation, as withholding analgesics while awaiting diagnosis impairs examination without improving diagnostic accuracy 1, 2, 3
• Pain assessment must begin at first contact and continue through discharge, according to the American Academy of Pediatrics 2, 4
• For mild to moderate pain, the American Academy of Pediatrics suggests administering oral ibuprofen 5-10 mg/kg every 6-8 hours or acetaminophen 10-15 mg/kg every 4-6 hours as first-line treatment if no contraindications exist 3, 5
• Oral opioids are appropriate for moderate pain if the patient can tolerate oral medications, as recommended by the American Academy of Pediatrics 1

Analgesic Selection by Pain Severity

• For severe pain, the American Academy of Pediatrics recommends administering IV opioid analgesics (morphine) titrated to effect using small, controlled doses 1, 3, 6
• Alternative routes include intranasal, transmucosal, or inhaled fentanyl when IV access is unavailable, though intranasal may cause nasal mucosal burning, as noted by the American Academy of Pediatrics 1
• The American Academy of Pediatrics advises avoiding the intramuscular route due to its painful nature and inability to allow titration 1, 3

Specific Condition Management

• For gastroenteritis-related abdominal pain, the American Academy of Pediatrics recommends assessing dehydration status first using physical examination and administering oral rehydration solution (ORS) accordingly 3
• For suspected appendicitis, the American Academy of Pediatrics suggests using validated scoring systems like the Pediatric Appendicitis Score to determine risk 7
• The American Academy of Pediatrics recommends antibiotic therapy for complicated appendicitis, with acceptable regimens including aminoglycoside-based, carbapenem, piperacillin-tazobactam, or advanced-generation cephalosporin with metronidazole 5, 6

Red Flags Requiring Immediate Surgical Evaluation

• The American Academy of Pediatrics recommends referring urgently for surgical consultation if signs of bowel obstruction, severe or persistent pain despite treatment, or signs of dehydration with inability to tolerate oral intake are present 3, 5

Nonpharmacologic Interventions

• The American Academy of Pediatrics suggests incorporating child life specialists and others trained in nonpharmacologic stress reduction to alleviate anxiety and perceived pain 2, 4
• Family presence during painful procedures is viable and useful in the acute care setting, according to the American Academy of Pediatrics 2, 4
• The American Academy of Pediatrics recommends using distraction techniques to improve pain management in children 1

Discharge Instructions

• The American Academy of Pediatrics recommends providing pain medication on discharge even for mild to moderate pain, with specific instructions regarding dose and duration 1, 2, 4
• Pain medication should be recommended around-the-clock for anyone in whom moderate pain is anticipated, as suggested by the American Academy of Pediatrics 1

Critical Pitfalls to Avoid

• The American Academy of Pediatrics advises never withholding pain medication while awaiting diagnosis, as this impairs examination without improving diagnostic accuracy 1, 2, 3, 5, 6
• The American Academy of Pediatrics recommends avoiding prolonged use of restrictive diets, as they result in inadequate energy and protein intake 3
• The American Academy of Pediatrics suggests avoiding the use of intramuscular injections when other routes are available, due to their painful nature and inability to allow titration 1, 3

Evidence‑Based Recommendations on the Use of GI Cocktails and Alternative Therapies for Pediatric Abdominal Pain

Safety Concerns of Traditional GI Cocktail Components

• Chronic antacid therapy is generally discouraged for treating gastro‑esophageal reflux disease (GERD) or abdominal pain in children because it is associated with higher rates of community‑acquired pneumonia, gastroenteritis, candidemia, and necrotizing enterocolitis in preterm infants. 8
• The antacid class, when used routinely or chronically in pediatric patients, presents risks that outweigh any potential benefit for abdominal pain management. 8
• Viscous lidocaine, a component of GI cocktails, carries pediatric‑specific hazards such as systemic absorption, central‑nervous‑system toxicity, and methemoglobinemia, which are amplified by children’s lower body mass and distinct pharmacokinetics. 8

Pharmacologic Alternatives for Suspected GERD‑Related Symptoms

• H₂‑receptor antagonists can be effective for pediatric GERD symptoms but are limited by tachyphylaxis after approximately six weeks and may increase the risk of liver disease and gynecomastia. 8
• Proton‑pump inhibitors (PPIs) are more efficacious than H₂ antagonists for pediatric GERD; however, they are linked to significant adverse events, including community‑acquired pneumonia and gastroenteritis. 8
• A non‑pharmacologic trial of dietary modification for two to four weeks is recommended before initiating any acid‑suppressive medication in children with suspected GERD. 8

Pharmacologic Alternatives for Functional Abdominal Pain

• Antispasmodic agents such as hyoscyamine or dicyclomine may be considered when functional abdominal pain is provoked by meals, although supporting evidence in children remains limited. 9
• Tricyclic antidepressants can be contemplated for children with frequent or severe functional abdominal pain, but the existing data are conflicting regarding efficacy and safety. 9

General Management of Underlying Conditions

• Management should focus on treating the specific underlying diagnosis (e.g., antibiotics for appendicitis, supportive care for pancreatitis, dietary modification for GERD) rather than employing a nonspecific GI cocktail. 8

Hyoscine Butylbromide: Pharmacology, Pediatric Use, and Adult Applications

Pharmacokinetics and Safety

• Hyoscine butylbromide does not cross the blood‑brain barrier because it is a quaternary ammonium compound, resulting in minimal central nervous system effects. 10

Pediatric Indications

• Evidence from a randomized controlled trial (Gut 2020) indicates that hyoscine butylbromide 10 mg orally can be considered an alternative antispasmodic for children with colicky abdominal pain when standard analgesics (ibuprofen or acetaminophen) are contraindicated or ineffective. 10

Adult Indications

• In adult practice, hyoscine butylbromide is widely employed as a gastrointestinal antispasmodic; oral administration has low systemic absorption, whereas intramuscular preparations may provide greater efficacy. 10
• For adult MR enterography, hyoscine butylbromide is the preferred spasmolytic agent to improve bowel distension. 11